annual meeting program - American Society of Clinical Oncology

Saturday, June 5, 2010
Brd. 50F Use of protein pathway mapping of brain metastasis from breast and lung
cancer patients to identify new therapeutic targets: A seed/soil study.
(Abstract #10620)
G. Improta, A. Zupa, J. Deng, H. Fillmore, M. Aieta, P. Musto, W. Broaddus,
L. A. Liotta, J. D. Wulfkuhle, E. Petricoin III
Brd. 50G Triple-negative breast cancers: Biomarkers and outcomes. (Abstract #10621)
L. Malorni, P. B. Shetty, S. G. Hilsenbeck, M. F. Rimawi, R. M. Elledge,
C. De Angelis, C. K. Osborne, S. De Placido, G. Arpino
Brd. 50H Effect of matrix metalloproteinase-2 on the ability of human dendritic cells to
prime inflammatory TH2 cells via an IL-12 and OX40L dependent pathway.
(Abstract #10622)
E. Godefroy
Brd. 51A Plasma levels of VEGF-A and VEGFR-2 in advanced NSCLC. (Abstract
#10623)
E. Sanmartin, E. Jantus, A. Blasco, R. Sirera, C. Caballero, S. Gallach,
R. M. Bremnes, N. del Pozo, A. Berrocal, C. Camps
Brd. 51B Use of quantum dots-based immunofluorescence nanotechnology for
quantitative HER2 and ER detection in breast cancer tissue array to identify
correlations in HER2-overexpressed and ER-positive breast cancer.
(Abstract #10624)
C. Chen, Y. Li, J. Peng, H. S. Xia, Y. P. Gong, D. W. Pang
Brd. 51C Effect of calcyclin-binding protein on proliferation and tumorigenicity of
pancreatic cancer. (Abstract #10625)
X. Chen
Brd. 51D Toll-like receptor (TLR) 7 and TLR8 expression in CD133� cells in colorectal
cancer and role for inflammation-induced TLRs in tumorigenesis and tumor
progression. (Abstract #10626)
M. Gasser, M. Grimm, M. Kim, A. Rosenwald, C. T. Germer, A. Waaga-Gasser
Brd. 51E Detection of aberrant SHP-1 promoter methylation, an implication in
advanced non-small cell lung cancer. (Abstract #10627)
C. Vinayanuwattikun, V. Sriuranpong, A. Mutirangura
Brd. 51F Neuropilin-2 and epithelial to mesenchymal transition in colorectal cancer
cells. (Abstract #10628)
C. Grandclement, R. Bedel, B. Kantelip, A. Bouard, V. Mougey, M. Klagsbrun,
C. Ferrand, P. Tiberghien, X. B. Pivot, C. Borg
Brd. 51G EMMPRIN up-regulates VEGFR-2 through HIF-2alpha mediated mechanism:
Consequences on angiogenesis and tumor progression. (Abstract #10629)
F. Bougatef, S. Menashi, C. Quemener, B. Naimi, M. Podgorniak, C. Dosquet,
F. M. Calvo, C. Lebbé, S. Mourah
Brd. 51H Evaluation of the combined expression of chemokine SDF-1� and its
receptor CXCR4 as a marker for prognosis in gastric cancer. (Abstract
#10630)
H. Lee, Y. Oh, H. Kim, S. Jin, H. Yun, D. Jo, S. F. Kim
Brd. 52A Evaluation of CYP24A1 mRNA expression as a prognostic marker and
predictor of calcitriol activity in lung adenocarcinoma. (Abstract #10631)
N. Ramnath, A. N. King, G. Chen, L. Zhao, R. U. Simpson, D. E. Brenner,
P. J. Christensen, D. G. Beer
Brd. 52B Integrated genomics-based discovery of new oncoproteins as a biomarker
and a molecular target for lung cancer. (Abstract #10632)
Y. Daigo, A. Takano, Y. Nakamura
Brd. 52C Interim analysis of CALGB 150607: A pilot project to study the expression of
MET and P53 in resected lung adenocarcinoma specimens. (Abstract #10633)
A. K. Salama, H. Pang, R. A. Kratzke, W. G. Richards, E. E. Vokes, R. Salgia
113
SATURDAY